Helen Rubenstein
Vice President of Investor Relations and Communications
Replay available
Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call
Neumora Therapeutics, Inc. (NASDAQ: NMRA) Q4 2024 earnings conference call, held 2025-03-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Paul Burns
Chief Executive Officer
Josh Pinto
President
Bill Arora
Chief Operating and Development Officer
Mike Milligan
Chief Financial Officer
Brian Abrahams
Analyst, RBC Capital Markets
Douglas Sao
Analyst, HC Wainwright
Delma Furiati
Analyst, Guggenheim
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neumora Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:01.974 Ladies and gentlemen, thank you for standing by. 00:00:01.974 -- 00:00:05.538 At this time, all participants are in listen-only mode. 00:00:05.538 -- 00:00:09.423 After the speaker's presentation, there will be a question and answer session. 00:00:09.423 -- 00:00:12.748 Please be advised that today's conference is being recorded. 00:00:12.748 -- 00:00:16.473 I would like to turn the conference over to Helen Rubenstein, Vice President of Investor 00:00:16.473 -- 00:00:21.156 Relations and Communications. Please go ahead. 00:00:21.680 -- 00:00:25.665 Good morning, and thank you for joining UMORA Therapeutics' fourth quarter and full year 00:00:25.665 -- 00:00:30.671 2024 Financial Results Conference call. Before we begin, I encourage everyone to go 00:00:30.671 -- 00:00:35.316 to the Investors and Media section of our website at numoratx.com, 00:00:35.316 -- 00:00:38.860 where you can find the press release related to today's call. 00:00:38.860 -- 00:00:44.047 With me on the call are Numora's Chief Executive Officer, Paul Burns, President, 00:00:44.047 -- 00:00:49.193 Josh Pinto, Chief Operating and Development Officer, Bill Arora, and Chief Financial 00:00:49.193 -- 00:00:51.355 Officer, Mike Milligan. 00:00:51.355 -- 00:00:54.880 I would like to point out that we will be making forward-looking statements, which are 00:00:54.880 -- 00:00:57.490 based on our current expectations and beliefs. 00:00:57.490 -- 00:01:02.074 These statements are subject to certain risks and uncertainties, and our actual results 00:01:02.074 -- 00:01:06.978 may differ materially. Please review the risk factors discussed in today's press release 00:01:06.978 -- 00:01:09.981 and in our SEC filings for additional details. 00:01:09.981 -- 00:01:13.144 With tha...